v3.25.4
NET LOSS PER SHARE (Tables)
9 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Schedule of Net Loss Per Share, Basic and Diluted
Basic and diluted net loss per share attributable to common stockholders was calculated as follows:
Three Months Ended
December 31,
Nine Months Ended
December 31,
2025202420252024
Numerator:
Net loss attributable to common stockholders—basic and diluted $(8,646)$(11,509)$(26,347)$(26,811)
Denominator:
Weighted average common shares outstanding—basic and diluted172,446,917 175,589,759 170,811,789 175,404,510 
Net loss per share attributable to common stockholders - basic and diluted$(0.05)$(0.07)$(0.15)$(0.15)
Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share
For the three and nine months ended December 31, 2025 and 2024, the Company excluded the following potential dilutive securities, which include stock options, RSUs, warrants and convertible notes from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted-average number of shares of common stock outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same for each of the three and nine months ended December 31, 2025 and 2024.
As of
December 31,
20252024
Stock options to purchase common stock8,812,525 10,321,196
Restricted stock units23,225,795 18,436,857 
Warrants to purchase common stock13,036,333 13,036,333
2025 Convertible Notes as converted to common stock— 4,307,607 
Employee Stock Purchase Plan291,434153,664